Director of Respiratory Care Research
New York University Grossman School of Medicine
Ivan Garcia is the Director of Respiratory Care Research for NYU Langone’s ASPIRE Trials Program. Mr. Garcia has extensive experience in the conduct of late-phase clinical trials in acute respiratory failure, and plays a key role in the PREVENT-VILI multicenter trial for moderate to severe ARDS (NCT06066502). He also co-led national coordination for the INSPiRE-ICU trials comparing propofol vs. inhaled isoflurane for mechanically ventilated patients. His research interest include ARDS, ventilator-induced lung injury, and patient-ventilator interactions, with expertise in esophageal manometry and lung-EIT.
Minimizing Lung Stress to Improve Survival in Acute Respiratory Distress Syndrome
Sunday, March 22, 2026
12:15 PM - 1:15 PM Central Time
Disclosure(s): Calcimedica: Contracted Research (Ongoing); nih/nhlbi: Grant/Research Support (Ongoing); Regeneron: Contracted Research (Ongoing); Sedana Medical: Contracted Research (Ongoing)
CD163 May Predict Lung Injury and Outcomes in Acute Respiratory Distress Syndrome
Sunday, March 22, 2026
12:15 PM - 1:15 PM Central Time
Disclosure(s): Calcimedica: Contracted Research (Ongoing); nih/nhlbi: Grant/Research Support (Ongoing); Regeneron: Contracted Research (Ongoing); Sedana Medical: Contracted Research (Ongoing)
Association Between Angiopoietin-2 and Multiorgan Dysfunction in ARDS Over Time
Sunday, March 22, 2026
2:45 PM - 3:45 PM Central Time
Disclosure(s): Calcimedica: Contracted Research (Ongoing); nih/nhlbi: Grant/Research Support (Ongoing); Regeneron: Contracted Research (Ongoing); Sedana Medical: Contracted Research (Ongoing)
Influence of Angiopoietin-2 on Sedation Depth in Patients With Acute Respiratory Distress Syndrome
Sunday, March 22, 2026
2:45 PM - 3:45 PM Central Time
Disclosure(s): Calcimedica: Contracted Research (Ongoing); nih/nhlbi: Grant/Research Support (Ongoing); Regeneron: Contracted Research (Ongoing); Sedana Medical: Contracted Research (Ongoing)
Oxygenation Index Tracks Clinical Outcomes and Biomarkers Better Than PaO2/FiO2 in Adults With ARDS
Monday, March 23, 2026
10:10 AM - 11:10 AM Central Time
Disclosure(s): Calcimedica: Contracted Research (Ongoing); nih/nhlbi: Grant/Research Support (Ongoing); Regeneron: Contracted Research (Ongoing); Sedana Medical: Contracted Research (Ongoing)
High Driving Pressures Are Associated With Lung Injury Biomarkers and Outcomes in ARDS
Monday, March 23, 2026
2:30 PM - 3:30 PM Central Time
Disclosure(s): Calcimedica: Contracted Research (Ongoing); nih/nhlbi: Grant/Research Support (Ongoing); Regeneron: Contracted Research (Ongoing); Sedana Medical: Contracted Research (Ongoing)
